Pictet Asset Management’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
Other funds holding COGT
TE
PCM
HWAM
KOCAA
PFSRSONJ
YIH
Pictet Asset Management's COGT Position: Q2 2026 in Review
Pictet Asset Management increased its Cogent Biosciences (COGT) stake by 33% in Q2 2026, buying an estimated $20.8M and bringing the position to 2,393,515 shares worth $92.6M. The position accounts for 0.09% of the portfolio, ranked #243.
Pictet Asset Management first reported a position in COGT in Q3 2024 and has held it in 8 quarters since. 47 funds tracked by Wall St. Rank hold COGT as of Q2 2026.
- Pictet Asset Management held 2,393,515 shares of Cogent Biosciences worth $92.6M as of Q2 2026.
- Pictet Asset Management bought 594,747 Cogent Biosciences shares in Q2 2026, an estimated $20.8M.
- Cogent Biosciences made up 0.09% of Pictet Asset Management's portfolio in Q2 2026, its #243 holding.
- Pictet Asset Management first reported a position in Cogent Biosciences in Q3 2024 and has held it in 8 quarters since.
- 47 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.
Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.